Catalyst Wire Dossier Catalyst Wire Dossier

RPTR-1-201

· Repertoire Immune Medicines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RPTR-1-201, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors [Phase 1, Phase 2]

See pricing